Determination of suitable antibiotics in treatment of Acinetobacter infections is through the hospital ascertaining the resistance state to bacteria causing the problem. In this study, the evaluation of antibiotics sensitivity of Acinetobacter strains isolated as infection factor in patients hospitalized in intensive care units is aimed.
Introduction
Acinetobacter is a gram-negative, coccobacillus, immobile, non-fermentative, opportunistic pathogen microorganism (1) . This pathogen can be commonly seen in intensive care units due to capability of staying alive in dry surfaces and colonizing in respiratory devices and human skin (2, 3) . It may cause meningitis, pneumonia, bacteremia and urinary system infection (3). Due to easily developing resistance to antimicrobial agents by various mechanisms, difficulties are experienced in its control and treatment (4, 5) . Antibiotic resistance may vary from hospital to hospital and determination of suitable antibiotic is vey important in treatment of Acinetobacter infections (1, 6) .
In this study, we aimed to evaluate the antibiotic sensitivity of Acinetobacter strains isolated as infection factor in intensive care units.
Material and Methods
In this study, the Acinetobacter strains isolated from the blood, urine, tracheal aspirate, wound site, catheter and other samples as infection factors from the patients hospitalized in Adult Intensive Care Units of 2 nd and 3 rd stage hospitals in a province of Northwestern Anatolia between 2014 and 2015 were studied. The samples were planted in 5% defibrinated sheep blood agar and Eosin Methylene-Blue mediums and incubated at 37°C. Sterile body samples were incubated for a maximum of 10 days at 37°C in bottles belonging to Bactec 9120 (Becton Dickinson, USA) blood culture system. After the bacteria is isolated, it is first evaluated by conventional methods. It is taken to panels belonging to BD Phoenix 100 (Becton Dickinson, USA) automated identification device for certain identification and determination of antimicrobial sensitivities. Amikacin, ampicilinesulbactam, gentamicin, imipenem, meropenem, ertapenem, cholistin, piperacillin-tazobactam, ceftriaxone, ciprofloxacin, tigecycline, trimethoprimsulfamethoxazole and aztreonam sensitivities were studied. A strain from each patient were studied, moderately sensitive strains were considered resistant. The results were interpreted according to CLSI standards.
Results
A total of 165 patients were included in the study and recurrent reproductions in each patient were not included in the study. Of the patients, 76 were female, 89 were male and age average was 73+17. Most commonly isolated samples were respiratory tract samples, blood and urine (Table 1) . Most sensitive antibiotics were cholistin (66,1%) gentamicin (22,4%) and trimethoprim sulfamethoxazole (18,2%) ( Table 2) . 
Discussion
The importance of Acinetobacter infections is increasing. Multiple antibiotic use with the increase in the number of intensive care units and patients is thought to be one of the considerable underlying causes of antibiotic resistance of microorganisms. This study showed that resistance for Acinetobacter infections is increasing in intensive care units. Difficulties in treatments related to multiple resistance are encountered.
Acinetobacter infections cause multiple drug resistance infections in parallel to increase risk factors such as duration of length of stay in intensive care unit, frequent use of antimicrobial agents, immunosuppressing, invasive procedures (7, 8) .
Acinetobacter infections are isolated from various samples. Acinetobacter infections are most commonly isolated from tracheal aspirates, wound site, blood and urine samples (9). Aral et al. (1) reported tracheal aspirate 30%, wound site 29% and blood 25%. Kurtoğlu et al. (10) have determined tracheal aspirate 42%, wound site 28%, urine 12% and blood 10%. Similarly, in our study, the bacteria was most commonly isolated in respiratory tract samples, blood and urine samples.
The resistance rates to carbapenems, quinolones and aminoglycosides in Acinetobacter strains increased to very high rates. At the same time, an increasing resistance against cholistin, which is used effectively in resistant strains, can be developed. Different Carbapenem resistance results for Acinetobacter have been reported in our country. A multi-centered HITI-1 study conducted in 2008, imipenem resistance in hospital-origin Acinetobacter strains was reported as 52,2% (11). This rate was reported as 61% by Mansur et al. (12) . In the intensive care units, Kuşçu et al. (13) have reported this ratio as 80%. In a multicenter study conducted in Korea, it was reported that imipenem resistance in A. baumannii increased from 52.9% to 89.8% (14) . The imipenem resistance ratio in the intensive care unit of our hospital was 93,3%. Ciprofloxacin, meanwhile, was found 84% in the study of Mansur et al. (12) , 82% in Balcı et al. (15) and 89% in Özer et al. (16) . This ratio was found as 98,8% in our own intensive care units. This finding is one of the highest ratios in our country. Additionally, there are different results of the studies in which the aminoglycoside resistance was investigated. The resistance rates for amikacin may vary between 71,6% and 94%, and for gentamicin 66-97% (12, 16, 17) . Gentamicin resistance (77,6%) was found lower than amikacin (90,9%) in our sudy. We believe this may be related to frequent preferrence of amikacin instead of gentamicin in treatment of nosocomial infections in our center. For Acinetobacter strains with multiple drug resistances, cholistin is considered as a suitable antibiotic. Cholistin resistance was reported to be less than 10% in our country (1) . In studies conducted in different countries it was reported as 5.3%, 3.6% and 0.7% (18, 19) . According to UHESA data, this resistance ratio is generally 2,95% in our country. This still makes us think cholistin a suitable treatment in Acinetobacter infection with multiple drup resistance treatment. However, we found a relatively high cholistin resistance in our intensive care units (33,9%).
In conclusion; we have demonstrated that a relatively high rate of resistance of antibiotics to clinically important Acinetobacter strains. Additionally, we also recommend that the intensive care unit personnel must be informed about bacteria infection control practices because of the tendency of these pathogens to persist and spread in the hospital environment easily.
